Company Search:
Advanced Search
Sponsored Links
Alnylam Pharmaceuticals, Inc. Company Snapshot
Alnylam Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alnylam Pharmaceuticals with three other companies in this sector in the United States: China Yct International Group, Inc. (2016 sales of $47.83 million ), Reliv' International, Inc. ($45.51 million ), and Theravance Biopharma Inc ($48.65 million of which 100% was Human Therapeutics).

Sales Analysis. During the year ended December of 2016, sales at Alnylam Pharmaceuticals were $47.16 million. This is an increase of 14.8% versus 2015, when the company's sales were $41.10 million. Despite this increase, sales are still below the level achieved in 2014, when Alnylam Pharmaceuticals reported sales of $50.56 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Alnylam Pharmaceuticals, Inc.
  Stock Performance Chart for Alnylam Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 129.07
(Figures in U.S. Dollars)
1 Week 1.0%   13 Weeks 2.8%  
4 Weeks 4.9%   52 Weeks 210.3%  
Alnylam Pharmaceuticals, Inc. Key Data:
  Ticker: ALNY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 47,159,000
(Year Ending Jan 2017).
Employees: 165
  Currency: U.S. Dollars Market Cap: 12,691,557,905
  Fiscal Yr Ends: December Shares Outstanding: 98,330,812
  Share Type: Common Closely Held Shares: 15,246,342
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.